(The Center Square) – The results of a May executive order aiming to reform drug pricing are beginning to materialize, per an administration announcement Tuesday. Major pharmaceutical manufacturer Pfizer has agreed to slash prices on many of its drugs in the U.S. after months of negotiations with the administration. Both those involved in the discussions and observers were uncertain how they would accomplish the president’s directive. Support this podcast: https://secure.anedot.com/franklin-news-foundation/ce052532-b1e4-41c4-945c-d7ce2f52c38a?source_code=xxxxxx Read more: https://www.thecentersquare.com/national/article_94a8607c-7183-49ca-bb55-7e072c680791.html Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
